Assessing the Impact of Inflation on Access to Anti-diabetic Drugs in Nigeria
In Nigeria, a staggering 80% of diabetic patients finance their medical bills through personal income or family support, with less than 10% having insurance coverage for essential medications and tests.[1] This low financial protection, coupled with the effect of inflation on the prices of antidiabetic medications has reduced diabetic patients’ adherence to treatment due to […]